Erol, C. Et Al. 2021. Efficacy and safety of perioperative FLOT (5-FU, LV, oxaliplatin, docetaxel) chemotherapy in gastric and gastroesophageal junction adenocarcinoma: Real-life data from Turkish oncology group. ANNALS OF ONCOLOGY , vol.32 .

Erol, C., Basoglu, T., Sakin, A., Ozden, E., Cubuk, D., Yumuk, P. F., ... Dogan, M.(2021). Efficacy and safety of perioperative FLOT (5-FU, LV, oxaliplatin, docetaxel) chemotherapy in gastric and gastroesophageal junction adenocarcinoma: Real-life data from Turkish oncology group. ANNALS OF ONCOLOGY , vol.32.

Erol, C. Et Al. "Efficacy and safety of perioperative FLOT (5-FU, LV, oxaliplatin, docetaxel) chemotherapy in gastric and gastroesophageal junction adenocarcinoma: Real-life data from Turkish oncology group," ANNALS OF ONCOLOGY , vol.32, 2021

Erol, C. Et Al. "Efficacy and safety of perioperative FLOT (5-FU, LV, oxaliplatin, docetaxel) chemotherapy in gastric and gastroesophageal junction adenocarcinoma: Real-life data from Turkish oncology group." ANNALS OF ONCOLOGY , vol.32, 2021

Erol, C. Et Al. (2021) . "Efficacy and safety of perioperative FLOT (5-FU, LV, oxaliplatin, docetaxel) chemotherapy in gastric and gastroesophageal junction adenocarcinoma: Real-life data from Turkish oncology group." ANNALS OF ONCOLOGY , vol.32.

@article{article, author={C. Erol Et Al. }, title={Efficacy and safety of perioperative FLOT (5-FU, LV, oxaliplatin, docetaxel) chemotherapy in gastric and gastroesophageal junction adenocarcinoma: Real-life data from Turkish oncology group}, journal={ANNALS OF ONCOLOGY}, year=2021}